|
Report Date : |
02.12.2014 |
IDENTIFICATION DETAILS
|
Name : |
BECTON DICKINSON MEDICAL (S) PTE LTD |
|
|
|
|
Registered Office : |
10, Collyer Quay, 10-01, Ocean Financial Centre, 049315 |
|
|
|
|
Country : |
Singapore |
|
|
|
|
Financials (as on) : |
30.09.2013 |
|
|
|
|
Date of Incorporation : |
27.07.1996 |
|
|
|
|
Com. Reg. No.: |
199605508-G |
|
|
|
|
Legal Form : |
Private Limited |
|
|
|
|
Line of Business : |
Manufacture of Medical Devices |
|
|
|
|
No. of Employees : |
400 [2014] |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Singapore |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
SINGAPORE - ECONOMIC OVERVIEW
Singapore has a highly developed and successful free-market
economy. It enjoys a remarkably open and corruption-free environment, stable
prices, and a per capita GDP higher than that of most developed countries. The
economy depends heavily on exports, particularly in consumer electronics,
information technology products, pharmaceuticals, and on a growing financial
services sector. The economy contracted 0.6% in 2009 as a result of the global
financial crisis, but rebounded 15.1% in 2010, on the strength of renewed
exports, before slowing to in 2011-13, largely a result of soft demand for
exports during the second European recession. Over the longer term, the
government hopes to establish a new growth path that focuses on raising
productivity. Singapore has attracted major investments in pharmaceuticals and
medical technology production and will continue efforts to establish Singapore
as Southeast Asia's financial and high-tech hub.
|
Source
: CIA |
|
REGISTRATION NO. |
: |
199605508-G |
|
COMPANY NAME |
: |
BECTON DICKINSON MEDICAL (S) PTE LTD |
|
FORMER NAME |
: |
N/A |
|
INCORPORATION DATE |
: |
27/07/1996 |
|
COMPANY STATUS |
: |
EXIST |
|
LEGAL FORM |
: |
PRIVATE LIMITED |
|
LISTED STATUS |
: |
NO |
|
REGISTERED ADDRESS |
: |
10, COLLYER QUAY, 10-01, OCEAN FINANCIAL CENTRE, 049315, SINGAPORE. |
|
BUSINESS ADDRESS |
: |
30, TUAS AVENUE 2, 639461, SINGAPORE. |
|
TEL.NO. |
: |
65-68610633 |
|
FAX.NO. |
: |
65-68601458 |
|
WEB SITE |
: |
WWW.BD.COM |
|
CONTACT PERSON |
: |
LIM LEONG CHING @ JAMES LIM ( DIRECTOR ) |
|
PRINCIPAL ACTIVITY |
: |
MANUFACTURE OF MEDICAL DEVICES |
|
ISSUED AND PAID UP CAPITAL |
: |
10,002.00 ORDINARY SHARE, OF A VALUE OF SGD 87,010,002.00 |
|
SALES |
: |
SGD 279,785,917 [2013] |
|
NET WORTH |
: |
SGD 545,171,594 [2013] |
|
STAFF STRENGTH |
: |
400 [2014] |
|
LITIGATION |
: |
CLEAR |
|
FINANCIAL CONDITION |
: |
STRONG |
|
PAYMENT |
: |
PROMPT |
|
MANAGEMENT CAPABILITY |
: |
AVERAGE |
|
COMMERCIAL RISK |
: |
LOW |
|
CURRENCY EXPOSURE |
: |
MODERATE |
|
GENERAL REPUTATION |
: |
GOOD |
|
INDUSTRY OUTLOOK |
: |
MATURE |
The Subject is a private limited company and is allowed to have a
minimum of one and a maximum of forty-nine shareholders. As a private limited
company, the Subject must have at least two directors. A private limited
company is a separate legal entity from its shareholders. As a separate legal
entity, the Subject is capable of owning assets, entering into contracts, sue
or be sued by other companies. The liabilities of the shareholders are to the
extent of the equity they have taken up and the creditors cannot claim on
shareholders' personal assets even if the Subject is insolvent. The Subject is
governed by the Companies Act and the company must file its annual returns,
together with its financial statements with the Registrar of Companies.
The Subject is principally engaged in the (as a / as an) manufacture of
medical devices.
The immediate holding company of the Subject is BECTON DICKINSON MEDICAL
PRODUCTS PTE LTD, a company incorporated in SINGAPORE.
The ultimate holding company of the Subject is BECTON DICKINSON AND
COMPANY, a company incorporated in UNITED STATES.
The intermediate holding company of the Subject is BECTON DICKINSON
HOLDINGS PTE LTD, a company incorporated in SINGAPORE.
Share Capital History
|
Date |
Issue & Paid Up Capital |
|
02/12/2014 |
SGD 87,010,002.00 |
The major shareholder(s) of the Subject are shown as follows :
|
Name |
Address |
IC/PP/Loc No |
Shareholding |
(%) |
|
BECTON DICKINSON MEDICAL PRODUCTS PTE LTD |
10, COLLYER QUAY, 10-01, OCEAN FINANCIAL CENTRE, 049315, SINGAPORE. |
198602285W |
10,002.00 |
100.00 |
|
--------------- |
------ |
|||
|
10,002.00 |
100.00 |
|||
|
============ |
===== |
+ Also Director
DIRECTOR 1
|
Name Of Subject |
: |
ROBERT THIBEAULT |
|
Address |
: |
336, LAUREL WOOD AVENUE, THE TENERIFFE, 275951, SINGAPORE. |
|
IC / PP No |
: |
S2736515I |
|
Nationality |
: |
SINGAPOREAN |
|
Date of Appointment |
: |
30/09/2011 |
DIRECTOR 2
|
Name Of Subject |
: |
BHUPINDER PAL SINGH |
|
Address |
: |
9, TANJONG RHU ROAD, 04-03, THE WATERSIDE, 436894, SINGAPORE. |
|
IC / PP No |
: |
S2756342B |
|
Nationality |
: |
SINGAPOREAN |
|
Date of Appointment |
: |
31/12/2011 |
DIRECTOR 3
|
Name Of Subject |
: |
LIM LEONG CHING @ JAMES LIM |
|
Address |
: |
62, TOH TUCK ROAD, 07-03, 596724, SINGAPORE. |
|
IC / PP No |
: |
S2563613I |
|
Nationality |
: |
SINGAPOREAN |
|
Date of Appointment |
: |
06/06/2008 |
|
1) |
Name of Subject |
: |
LIM LEONG CHING @ JAMES LIM |
|
Position |
: |
DIRECTOR |
|
|
Auditor |
: |
ERNST & YOUNG LLP |
|
Auditor' Address |
: |
N/A |
|
1) |
Company Secretary |
: |
TAN CHING CHING |
|
IC / PP No |
: |
S7378437I |
|
|
Address |
: |
4B, ST. GEORGE'S LANE, 06-169, 321004, SINGAPORE. |
|
No Banker found in our databank.
No encumbrance was found in our databank at the time of investigation.
* A check has been conducted in our databank againt the Subject whether the
subject has been involved in any litigation.
No legal action was found in our databank.
No winding up petition was found in our databank.
|
SOURCES OF RAW MATERIALS: |
||
|
Local |
: |
N/A |
|
Overseas |
: |
N/A |
The Subject refused to disclose it's suppliers.
The Subject refused to provide any name of trade/service supplier and we are
unable to conduct any trade enquiry. However, from financial historical data we
conclude that :
|
OVERALL PAYMENT HABIT |
||||||||||||||
|
Prompt 0-30 Days |
[ |
X |
] |
Good 31-60 Days |
[ |
] |
Average 61-90 Days |
[ |
] |
|||||
|
Fair 91-120 Days |
[ |
] |
Poor >120 Days |
[ |
] |
|||||||||
|
Local |
: |
YES |
|||
|
Domestic Markets |
: |
SINGAPORE |
|||
|
Overseas |
: |
YES |
|||
|
Export Market |
: |
WORLDWIDE |
|||
|
Credit Term |
: |
N/A |
|||
|
Payment Mode |
: |
N/A |
|||
|
Products manufactured |
: |
|
|
|
Total Number of Employees: |
|
||||||||
|
YEAR |
2014 |
2013 |
2012 |
||||||
|
GROUP |
N/A |
N/A |
N/A |
||||||
|
COMPANY |
400 |
400 |
400 |
||||||
|
Branch |
: |
NO |
Other Information:
The Subject is principally engaged in the (as a / as an) manufacture of medical
devices.
The Subject's business consists of manufacture and sales of healthcare
products.
Background of Becton Dickinson (BD) Group:
BD is a medical technology company that serves healthcare institutions, life
science researchers, clinical laboratories, industry and the general public. BD
manufactures and sells a broad range of medical supplies, devices, laboratory
equipment and diagnostic products. BD is headquartered in the United States and
has offices in nearly 50 countries worldwide.
Products and services:
* medical equipment & supplies
* rehabilitation equipment & supplies
* surgical equipment & supplies
* wheel chairs
Latest fresh investigations carried out on the Subject indicated that :
|
Telephone Number Provided By Client |
: |
N/A |
|
Current Telephone Number |
: |
65-68610633 |
|
Match |
: |
N/A |
|
Address Provided by Client |
: |
30TUAS AVENUE 2, SINGAPORE 639461 SINGAPORE |
|
Current Address |
: |
30, TUAS AVENUE 2, 639461, SINGAPORE. |
|
Match |
: |
YES |
Other Investigations
On 2nd December 2014 we contacted one of the staff from the Subject and she provided
some information on the Subject.
The Subject refused to disclose it's bankers.
|
Profitability |
||||||
|
Turnover |
: |
Erratic |
[ |
2009 - 2013 |
] |
|
|
Profit/(Loss) Before Tax |
: |
Decreased |
[ |
2009 - 2013 |
] |
|
|
Return on Shareholder Funds |
: |
Acceptable |
[ |
16.11% |
] |
|
|
Return on Net Assets |
: |
Acceptable |
[ |
16.72% |
] |
|
|
The fluctuating turnover reflects the fierce competition among the existing
and new market players.The dip in profit could be due to the stiff market
competition which reduced the Subject's profit margin. The Subject's
management had generated acceptable return for its shareholders using its
assets. |
||||||
|
Working Capital Control |
||||||
|
Stock Ratio |
: |
Favourable |
[ |
36 Days |
] |
|
|
Debtor Ratio |
: |
Favourable |
[ |
0 Days |
] |
|
|
Creditors Ratio |
: |
Favourable |
[ |
20 Days |
] |
|
|
The Subject's stocks were moving fast thus reducing its holding cost.
This had reduced funds being tied up in stocks. The favourable debtors' days
could be due to the good credit control measures implemented by the Subject.
The Subject had a favourable creditors' ratio where the Subject could be
taking advantage of the cash discounts and also wanting to maintain goodwill
with its creditors. |
||||||
|
Liquidity |
||||||
|
Liquid Ratio |
: |
Favourable |
[ |
10.70 Times |
] |
|
|
Current Ratio |
: |
Favourable |
[ |
11.52 Times |
] |
|
|
A minimum liquid ratio of 1 should be maintained by the Subject in
order to assure its creditors of its ability to meet short term obligations and
the Subject was in a good liquidity position. Thus, we believe the Subject is
able to meet all its short term obligations as and when they fall due. |
||||||
|
Solvency |
||||||
|
Interest Cover |
: |
Nil |
[ |
0.00 Times |
] |
|
|
Gearing Ratio |
: |
Favourable |
[ |
0.00 Times |
] |
|
|
The Subject's interest cover was nil as it did not pay any interest
during the year. The Subject had no gearing and hence it had virtually no financial
risk. The Subject was financed by its shareholders' funds and internally
generated fund. During the economic downturn, the Subject, having a zero
gearing, will be able to compete better than those which are highly geared in
the same industry. |
||||||
|
Overall Assessment : |
||||||
|
The Subject recorded lower profits as its turnover showed a erratic
trend. The Subject's management was unable to control its costs efficiently as
its profit showed a downward trend. The Subject was in good liquidity
position with its total current liabilities well covered by its total current
assets. With its current net assets, the Subject should be able to repay its
short term obligations. The Subject did not make any interest payment during
the year. The Subject was dependent on its shareholders' funds to finance its
business needs. The Subject was a zero gearing company, it was solely
dependant on its shareholders to provide funds to finance its business. The
Subject has good chance of getting loans, if the needs arises. |
||||||
|
Overall financial condition of the Subject : STRONG |
||||||
|
Major Economic Indicators : |
2009 |
2010 |
2011 |
2012 |
2013 |
|
|
|||||
|
Population (Million) |
4.98 |
5.08 |
5.18 |
5.31 |
5.40 |
|
Gross Domestic Products ( % ) |
(0.8) |
14.5 |
4.9 |
1.3 |
3.7 |
|
Consumer Price Index |
0.6 |
2.8 |
5.2 |
4.6 |
2.4 |
|
Total Imports (Million) |
356,299.3 |
423,221.8 |
459,655.1 |
474,554.0 |
466,762.0 |
|
Total Exports (Million) |
391,118.1 |
478,840.7 |
514,741.2 |
510,329.0 |
513,391.0 |
|
|
|||||
|
Unemployment Rate (%) |
3.2 |
2.2 |
2.1 |
2.0 |
1.9 |
|
Tourist Arrival (Million) |
9.68 |
11.64 |
13.17 |
14.49 |
15.46 |
|
Hotel Occupancy Rate (%) |
75.8 |
85.6 |
86.5 |
86.4 |
86.3 |
|
Cellular Phone Subscriber (Million) |
1.37 |
1.43 |
1.50 |
1.52 |
1.97 |
|
|
|||||
|
Registration of New Companies (No.) |
26,414 |
29,798 |
32,317 |
31,892 |
37,288 |
|
Registration of New Companies (%) |
4.3 |
12.8 |
8.5 |
(1.3) |
9.8 |
|
Liquidation of Companies (No.) |
22,393 |
15,126 |
19,005 |
17,218 |
17,369 |
|
Liquidation of Companies (%) |
113.4 |
(32.5) |
25.6 |
9.4 |
(5.3) |
|
|
|||||
|
Registration of New Businesses (No.) |
26,876 |
23,978 |
23,494 |
24,788 |
22,893 |
|
Registration of New Businesses (%) |
8.15 |
(10.78) |
2.02 |
5.51 |
1.70 |
|
Liquidation of Businesses (No.) |
23,552 |
24,211 |
23,005 |
22,489 |
22,598 |
|
Liquidation of Businesses (%) |
11.4 |
2.8 |
(5) |
(2.2) |
0.5 |
|
|
|||||
|
Bankruptcy Orders (No.) |
2,058 |
1,537 |
1,527 |
1,748 |
1,992 |
|
Bankruptcy Orders (%) |
(11.5) |
(25.3) |
(0.7) |
14.5 |
14.0 |
|
Bankruptcy Discharges (No.) |
3,056 |
2,252 |
1,391 |
1,881 |
2,584 |
|
Bankruptcy Discharges (%) |
103.7 |
(26.3) |
(38.2) |
35.2 |
37.4 |
|
|
|||||
|
INDUSTRIES ( % of Growth ) : |
|||||
|
Agriculture |
|||||
|
Production of Principal Crops |
3.25 |
(0.48) |
4.25 |
3.64 |
- |
|
Fish Supply & Wholesale |
(1.93) |
(10.5) |
12.10 |
(0.5) |
- |
|
|
|||||
|
Manufacturing * |
71.5 |
92.8 |
100.0 |
100.3 |
102.0 |
|
Food, Beverages & Tobacco |
90.4 |
96.4 |
100.0 |
103.5 |
103.5 |
|
Textiles |
145.9 |
122.1 |
100.0 |
104.0 |
87.1 |
|
Wearing Apparel |
211.0 |
123.3 |
100.0 |
92.1 |
77.8 |
|
Leather Products & Footwear |
79.5 |
81.8 |
100.0 |
98.6 |
109.8 |
|
Wood & Wood Products |
101.4 |
104.0 |
100.0 |
95.5 |
107.4 |
|
Paper & Paper Products |
95.4 |
106.1 |
100.0 |
97.4 |
103.2 |
|
Printing & Media |
100.9 |
103.5 |
100.0 |
93.0 |
86.1 |
|
Crude Oil Refineries |
96.4 |
95.6 |
100.0 |
99.4 |
93.5 |
|
Chemical & Chemical Products |
80.3 |
97.6 |
100.0 |
100.5 |
104.1 |
|
Pharmaceutical Products |
49.1 |
75.3 |
100.0 |
109.7 |
107.2 |
|
Rubber & Plastic Products |
101.2 |
112.3 |
100.0 |
96.5 |
92.9 |
|
Non-metallic Mineral |
91.9 |
92.5 |
100.0 |
98.2 |
97.6 |
|
Basic Metals |
92.6 |
102.2 |
100.0 |
90.6 |
76.5 |
|
Fabricated Metal Products |
90.8 |
103.6 |
100.0 |
104.3 |
105.1 |
|
Machinery & Equipment |
57.3 |
78.5 |
100.0 |
112.9 |
114.5 |
|
Electrical Machinery |
86.8 |
124.1 |
100.0 |
99.3 |
108.5 |
|
Electronic Components |
85.2 |
113.6 |
100.0 |
90.6 |
94.3 |
|
Transport Equipment |
96.0 |
94.0 |
100.0 |
106.3 |
107.5 |
|
|
|||||
|
Construction |
(36.9) |
14.20 |
20.50 |
28.70 |
- |
|
Real Estate |
1.4 |
21.3 |
25.4 |
31.9 |
- |
|
|
|||||
|
Services |
|||||
|
Electricity, Gas & Water |
1.70 |
4.00 |
7.00 |
6.30 |
- |
|
Transport, Storage & Communication |
3.90 |
12.80 |
7.40 |
5.30 |
- |
|
Finance & Insurance |
(16.4) |
(0.4) |
8.90 |
0.50 |
- |
|
Government Services |
4.50 |
9.70 |
6.90 |
6.00 |
- |
|
Education Services |
0.10 |
(0.9) |
(1.4) |
0.30 |
- |
|
|
|||||
|
* Based on Index of Industrial Production (2011 = 100) |
INDUSTRY: MANUFACTURING
In the third quarter of 2014, manufacturing output has increased by
1.9%, extending the 1.5% growth in the previous quarter. Growth was largely
driven by the biomedical manufacturing and chemicals clusters. Besides, for the
whole 2013, the manufacturing sector grew by 1.7%, an uptick from the 0.3%
growth recorded in the previous year. All clusters recorded an expansion in
2013, except the biomedical manufacturing cluster.
The chemicals cluster grew by 5.2% in the third quarter of 2014. Growth
was led by the petrochemicals and specialty chemicals segments, which expanded
by 8.9% and 7.1% respectively. By contrast, the petroleum segment contracted by
4.2% in the third quarter of 2014 due to plant maintenance shutdowns. For the
year of 2013, the chemicals cluster grew only by 0.7%.
Besides, output of the biomedical manufacturing cluster expanded by 9.0%
in the third quarter of 2014. The medical technology segment posted robust
growth of 23% due to higher production of medical instruments and supplies,
while the output of the pharmaceuticals segment rose by 6.2%. However, in the
whole of 2013, the biomedical manufacturing cluster recorded only a flat
growth.
In the third quarter of 2014, the transport engineering cluster
contracted by 2.0%, dragged down by the aerospace segment. Output in the
aerospace segment plunged by 18% on the back of fewer repair jobs from
commercial airlines. This was mitigated by the 4.1% growth in the marine &
offshore engineering segment, which was supported by higher contributions from
rig building projects. Nonetheless, for the whole of 2013, the transport
engineering cluster grew by 5.2%.
Moreover, output of the precision engineering cluster increased by 1.3%
in the third quarter of 2014. The machinery & systems segment grew by 6.2%,
supported by higher demand for semiconductor-related equipment and mechanical
engineering work. This was partly offset by the decline in the output of the
precision modules & components segment. Conversely, in the full year of
2013, the precision engineering cluster's output declined by 5.6%.
Furthermore, in the third quarter of 2014, output of the general
manufacturing industries declined by 3.0%. The 2.1% growth in the food,
beverages & tobacco segment was more than offset by declines in the other
two segments. In particular, the miscellaneous industries segment contracted by
4.7% on the back of lower output in construction-related products, such as
concrete & cement products and steel structural components. For the full
year of 2013, the general manufacturing cluster grew by 2.8%.
Besides, in the third quarter of 2014, the electronics cluster expanded
by 0.9%, reversing the 5.0% contraction in the previous quarter. Growth was supported
by an expansion in the computer peripherals (6.3%) and data storage (2.6%)
segments. Moreover, for the year 2013, the electronics cluster expanded by
3.5%.
OVERALL INDUSTRY OUTLOOK : MATURE
Incorporated in 1996, the Subject is a Private Limited company, focusing on
manufacture of medical devices. With its long establishment in the market, the
Subject has received strong support from its stable customers base. Its
business position in the market is quite stable and it is expected to enjoy
better market shares over its rivals. The Subject is a large entity with strong
capital position of SGD 87,010,002. We are confident with the Subject's
business and its future growth prospect. Having strong support from its holding
company has enabled the Subject to remain competitive despite the challenging
business environment.
Over the years, the Subject has penetrated into both the local and
overseas market. The Subject has positioned itself in the global market and is
competing in the industry. Its stable clientele base will enable the Subject to
further enhance its business in the near term. The Subject is a fairly large
and rapidly growing company with over 400 staff in its operations Overall, we
regard that the Subject's management capability is average. This indicates that
the Subject has greater potential to improve its business performance and
raising income for the Subject.
The Subject's business performance showed a reverse trend as both its turnover
and pre-tax profit have decreased compared to the previous year. Return on
shareholders' funds of the Subject was at an acceptable range which indicated
that the management was efficient in utilising its funds to generate income.
The Subject is in good liquidity position with its current liabilities well
covered by it current assets. Hence, it has sufficient working capital to meet
its short term financial obligations. Being a zero geared company, the Subject
virtually has no financial risk as it is mainly dependent on its internal funds
to finance its business. Given a positive net worth standing at SGD
545,171,594, the Subject should be able to maintain its business in the near
terms.
Having a strong assets backing, the Subject possesses latent assets as collateral
for further financial extension. Hence, it has good chance of getting loans if
the needs arises.
We regard that the Subject's overall payment habit is prompt. The Subject had a
favourable creditors' ratio as evidenced by its favourable collection days.
The industry has reached its optimum level and is generally stable. It is
saturated and very competitive. Thus, the Subject's growth prospect is very
much depends on its capacity in sustaining its performance in the market.
Based on the above condition, we recommend credit be granted to the Subject
promptly.
|
THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH SINGAPORE
FINANCIAL REPORTING STANDARDS. |
|
BECTON DICKINSON MEDICAL (S) PTE LTD |
|
Financial Year End |
2013-09-30 |
2012-09-30 |
2011-09-30 |
2010-09-30 |
2009-09-30 |
|
Months |
12 |
12 |
12 |
12 |
12 |
|
Consolidated Account |
Company |
Company |
Company |
Company |
Company |
|
Audited Account |
YES |
YES |
YES |
YES |
YES |
|
Unqualified Auditor's Report (Clean Opinion) |
YES |
YES |
YES |
YES |
YES |
|
Financial Type |
FULL |
FULL |
FULL |
FULL |
FULL |
|
Currency |
SGD |
SGD |
SGD |
SGD |
SGD |
|
TURNOVER |
279,785,917 |
312,718,144 |
220,170,973 |
177,829,886 |
183,506,150 |
|
Other Income |
955,834 |
1,067,860 |
750,167 |
1,084,825 |
- |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
Total Turnover |
280,741,751 |
313,786,004 |
220,921,140 |
178,914,711 |
183,506,150 |
|
Costs of Goods Sold |
(179,950,893) |
(189,847,505) |
(149,382,772) |
(116,569,962) |
- |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
Gross Profit |
100,790,858 |
123,938,499 |
71,538,368 |
62,344,749 |
- |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
PROFIT/(LOSS) FROM OPERATIONS |
92,396,401 |
97,343,327 |
57,931,033 |
50,015,977 |
59,760,514 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
PROFIT/(LOSS) BEFORE TAXATION |
92,396,401 |
97,343,327 |
57,931,033 |
50,015,977 |
59,760,514 |
|
Taxation |
(4,559,529) |
(5,115,484) |
(4,558,212) |
(1,876,139) |
(690,320) |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
PROFIT/(LOSS) AFTER TAXATION |
87,836,872 |
92,227,843 |
53,372,821 |
48,139,838 |
59,070,194 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
RETAINED PROFIT/(LOSS) BROUGHT FORWARD |
|||||
|
As previously reported |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
254,610,024 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
As restated |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
254,610,024 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
PROFIT AVAILABLE FOR APPROPRIATIONS |
548,161,592 |
460,324,720 |
368,096,877 |
356,520,056 |
313,680,218 |
|
DIVIDENDS - Ordinary (paid & proposed) |
(90,000,000) |
- |
- |
(41,796,000) |
(5,300,000) |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
RETAINED PROFIT/(LOSS) CARRIED FORWARD |
458,161,592 |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
|
============= |
============= |
============= |
============= |
============= |
|
|
INTEREST EXPENSE (as per notes to P&L) |
|||||
|
Others |
- |
- |
3,166 |
23 |
502 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
- |
- |
3,166 |
23 |
502 |
|
|
============= |
============= |
============= |
============= |
|
BECTON DICKINSON MEDICAL (S) PTE LTD |
|
ASSETS EMPLOYED: |
|||||
|
FIXED ASSETS |
202,314,020 |
191,643,324 |
166,549,963 |
131,148,675 |
114,312,885 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL LONG TERM ASSETS |
202,314,020 |
191,643,324 |
166,549,963 |
131,148,675 |
114,312,885 |
|
Stocks |
27,391,457 |
24,622,784 |
33,543,609 |
23,269,765 |
20,464,302 |
|
Other debtors, deposits & prepayments |
2,937,195 |
1,649,609 |
1,886,506 |
2,265,998 |
1,463,561 |
|
Amount due from holding company |
60,633,461 |
70,147,903 |
5,872,296 |
8,625,655 |
6,389,102 |
|
Amount due from related companies |
269,697,052 |
272,074,152 |
48,110,464 |
20,385,500 |
24,611,295 |
|
Cash & bank balances |
21,783,145 |
18,335,359 |
17,670,423 |
6,482,607 |
4,159,144 |
|
Others |
1,101,114 |
8,012,309 |
226,008,732 |
243,936,062 |
250,962,006 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL CURRENT ASSETS |
383,543,424 |
394,842,116 |
333,092,030 |
304,965,587 |
308,049,410 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL ASSET |
585,857,444 |
586,485,440 |
499,641,993 |
436,114,262 |
422,362,295 |
|
============= |
============= |
============= |
============= |
============= |
|
|
CURRENT LIABILITIES |
|||||
|
Trade creditors |
10,105,217 |
9,853,264 |
8,177,343 |
14,766,700 |
5,656,353 |
|
Other creditors & accruals |
10,989,298 |
9,544,044 |
7,982,271 |
9,555,236 |
7,868,751 |
|
Amounts owing to holding company |
1,056,957 |
683,152 |
1,198,517 |
1,500,378 |
3,271,948 |
|
Amounts owing to related companies |
5,762,946 |
6,768,205 |
9,689,393 |
2,294,541 |
3,155,493 |
|
Provision for taxation |
5,365,278 |
5,515,426 |
2,434,150 |
2,338,243 |
2,967,497 |
|
Other liabilities |
- |
- |
8,242,959 |
- |
- |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL CURRENT LIABILITIES |
33,279,696 |
32,364,091 |
37,724,633 |
30,455,098 |
22,920,042 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
NET CURRENT ASSETS/(LIABILITIES) |
350,263,728 |
362,478,025 |
295,367,397 |
274,510,489 |
285,129,368 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL NET ASSETS |
552,577,748 |
554,121,349 |
461,917,360 |
405,659,164 |
399,442,253 |
|
============= |
============= |
============= |
============= |
============= |
|
|
SHARE CAPITAL |
|||||
|
Ordinary share capital |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL SHARE CAPITAL |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
|
Retained profit/(loss) carried forward |
458,161,592 |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL RESERVES |
458,161,592 |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
SHAREHOLDERS' FUNDS/EQUITY |
545,171,594 |
547,334,722 |
455,106,879 |
401,734,058 |
395,390,220 |
|
Deferred taxation |
7,406,154 |
6,786,627 |
6,800,326 |
3,884,925 |
3,965,500 |
|
Others |
- |
- |
10,155 |
40,181 |
86,533 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
TOTAL LONG TERM LIABILITIES |
7,406,154 |
6,786,627 |
6,810,481 |
3,925,106 |
4,052,033 |
|
---------------- |
---------------- |
---------------- |
---------------- |
---------------- |
|
|
552,577,748 |
554,121,349 |
461,917,360 |
405,659,164 |
399,442,253 |
|
|
============= |
============= |
============= |
============= |
============= |
|
|
BECTON DICKINSON MEDICAL (S) PTE LTD |
|
TYPES OF FUNDS |
|||||
|
Cash |
21,783,145 |
18,335,359 |
17,670,423 |
6,482,607 |
4,159,144 |
|
Net Liquid Funds |
21,783,145 |
18,335,359 |
17,670,423 |
6,482,607 |
4,159,144 |
|
Net Liquid Assets |
322,872,271 |
337,855,241 |
261,823,788 |
251,240,724 |
264,665,066 |
|
Net Current Assets/(Liabilities) |
350,263,728 |
362,478,025 |
295,367,397 |
274,510,489 |
285,129,368 |
|
Net Tangible Assets |
552,577,748 |
554,121,349 |
461,917,360 |
405,659,164 |
399,442,253 |
|
Net Monetary Assets |
315,466,117 |
331,068,614 |
255,013,307 |
247,315,618 |
260,613,033 |
|
BALANCE SHEET ITEMS |
|||||
|
Total Borrowings |
0 |
0 |
0 |
0 |
0 |
|
Total Liabilities |
40,685,850 |
39,150,718 |
44,535,114 |
34,380,204 |
26,972,075 |
|
Total Assets |
585,857,444 |
586,485,440 |
499,641,993 |
436,114,262 |
422,362,295 |
|
Net Assets |
552,577,748 |
554,121,349 |
461,917,360 |
405,659,164 |
399,442,253 |
|
Net Assets Backing |
545,171,594 |
547,334,722 |
455,106,879 |
401,734,058 |
395,390,220 |
|
Shareholders' Funds |
545,171,594 |
547,334,722 |
455,106,879 |
401,734,058 |
395,390,220 |
|
Total Share Capital |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
87,010,002 |
|
Total Reserves |
458,161,592 |
460,324,720 |
368,096,877 |
314,724,056 |
308,380,218 |
|
LIQUIDITY (Times) |
|||||
|
Cash Ratio |
0.65 |
0.57 |
0.47 |
0.21 |
0.18 |
|
Liquid Ratio |
10.70 |
11.44 |
7.94 |
9.25 |
12.55 |
|
Current Ratio |
11.52 |
12.20 |
8.83 |
10.01 |
13.44 |
|
WORKING CAPITAL CONTROL (Days) |
|||||
|
Stock Ratio |
36 |
29 |
56 |
48 |
41 |
|
Debtors Ratio |
0 |
0 |
0 |
0 |
0 |
|
Creditors Ratio |
20 |
19 |
20 |
46 |
11 |
|
SOLVENCY RATIOS (Times) |
|||||
|
Gearing Ratio |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
Liabilities Ratio |
0.07 |
0.07 |
0.10 |
0.09 |
0.07 |
|
Times Interest Earned Ratio |
0.00 |
0.00 |
18,298.86 |
2,174,608.70 |
119,045.85 |
|
Assets Backing Ratio |
6.35 |
6.37 |
5.31 |
4.66 |
4.59 |
|
PERFORMANCE RATIO (%) |
|||||
|
Operating Profit Margin |
33.02 |
31.13 |
26.31 |
28.13 |
32.57 |
|
Net Profit Margin |
31.39 |
29.49 |
24.24 |
27.07 |
32.19 |
|
Return On Net Assets |
16.72 |
17.57 |
12.54 |
12.33 |
14.96 |
|
Return On Capital Employed |
16.72 |
17.57 |
12.54 |
12.33 |
14.96 |
|
Return On Shareholders' Funds/Equity |
16.11 |
16.85 |
11.73 |
11.98 |
14.94 |
|
Dividend Pay Out Ratio (Times) |
1.02 |
0.00 |
0.00 |
0.87 |
0.09 |
|
NOTES TO ACCOUNTS |
|||||
|
Contingent Liabilities |
0 |
0 |
0 |
0 |
0 |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.14 |
|
UK Pound |
1 |
Rs.97.05 |
|
Euro |
1 |
Rs.77.37 |
INFORMATION DETAILS
|
Analysis Done by
: |
KAR |
|
|
|
|
Report Prepared by
: |
SHG |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors and their relative weights (as
indicated through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.